Association of Slowly Expanding Lesions on MRI With Disability in People With Secondary Progressive Multiple Sclerosis | Neurology
Secondary Progressive Multiple Sclerosis (SPMS) - A Case Study - Physiopedia
MS Types
Types of MS | MS Trust
Multiple Sclerosis: Facts, Statistics, and You
What Does It Mean if You Have Secondary Progressive Multiple Sclerosis?
Frontiers | Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis
Secondary-Progressive MS: What Is It, and When Does It Start?
Novartis data show early treatment with Mayzent® (siponimod) delays disability progression and show benefits in cognitive performance in patients with secondary progressive multiple sclerosis (SPMS)
Multiple Sclerosis Trust - NHS England has agreed that Mayzent (siponimod) can be prescribed for people with active secondary progressive multiple sclerosis whose MS has progressed despite taking a disease modifying drug.
Treatment licensed in US for active secondary progressive MS
Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function - The Lancet